The impaired apolipoprotein subparticle measures of Lp-B:C and Lp-A-I:A-II in the subjects with PAD also support previous work that subjects with more severe PAD requiring revascularization had impaired apolipoprotein profiles compared to controls [25]. This evidence concerns the gene LPA and peripheral arterial disease.